Viral Infection, Covid-19, Virus, Technology, Nanoparticles.
vivo studies were carried out to assess its ability to passivate SARS-CoV-2. Computational modelling was the key to achieve this goal quickly and in a time in which most experimental facilities were unavailable owing to safety restrictions. ‘We would not have developed a therapy or so many other